The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.
< 1.000 Eu/µg
Concentration information loading...
Preparation and Storage
Stability and Storage
Shipped at 4°C. Store at +4°C short term (1-2 weeks). Upon delivery aliquot. Store at -80°C. Avoid freeze / thaw cycle. For long term storage it is recommended to add a carrier protein on reconstitution (0.1% HSA or BSA).
pH: 7.40 Constituents: 95% PBS, 5% Trehalose
It is recommended to reconstitute the lyophilized product in 50 µl sterile deionized water to a final concentration of 1 mg/ml. Solubilize for 30 to 60 minutes at room temperature with occasional gentle mixing. Carrier protein (0.1% HSA or BSA) is strongly recommended for further dilution and long term storage
47 kDa heat shock protein
47 kDa heat shock protein precursor
Arsenic transactivated protein 3
Arsenic-transactivated protein 3
Cell proliferation-inducing gene 14 protein
Collagen binding protein
Collagen binding protein 1
Collagen binding protein 2
Collagen-binding protein 2
Heat shock protein 47
Heat-shock protein 47
Proliferation inducing gene 14
Proliferation inducing gene 14 protein
Rheumatoid arthritis antigen A 47
rheumatoid arthritis antigen A-47
Rheumatoid arthritis related antigen RA A47
Rheumatoid arthritis-related antigen RA-A47
serine (or cysteine) proteinase inhibitor, clade H (heat shock protein 47), member 1, (collagen binding protein 1)
serine (or cysteine) proteinase inhibitor, clade H (heat shock protein 47), member 2, (collagen-binding protein 2)
Serine or cysteine proteinase inhibitor clade H member 1
Serine or cysteine proteinase inhibitor clade H member 2
Serpin peptidase inhibitor clade H member 1
serpin peptidase inhibitor, clade H (heat shock protein 47), member 1, (collagen binding protein 1)
Serpin peptidase inhibitor, clade H, member 1
Binds specifically to collagen. Could be involved as a chaperone in the biosynthetic pathway of collagen.
Involvement in disease
Note=Defects in SERPINH1 may cause severe autosomal recessive osteogenesis imperfecta (OI). Osteogenesis imperfecta defines a group of connective tissue disorders characterized by bone fragility and low bone mass.